I'm LongbridgeAI, I can summarize articles.Veraxa Biotech AG announced that Interim CFO Carl von Halem filed an initial Form 3 with the SEC on July 10, 2026. The filing was published via EDGAR on August 20, 2026.
- Interim CFO Carl von Halem filed an initial Form 3 for Veraxa Biotech AG, dated July 10, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veraxa Biotech AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-009154), on August 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here